0R6Y logo

Thor Medical LSE:0R6Y Stock Report

Last Price

kr1.02

Market Cap

kr240.5m

7D

14.0%

1Y

n/a

Updated

27 Mar, 2024

Data

Company Financials

0R6Y Stock Overview

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway.

0R6Y fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Thor Medical ASA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Thor Medical
Historical stock prices
Current Share Pricekr1.02
52 Week Highkr2.00
52 Week Lowkr1.03
Beta0
1 Month Change-3.24%
3 Month Change-21.12%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-49.15%

Recent News & Updates

Recent updates

Shareholder Returns

0R6YGB BiotechsGB Market
7D14.0%1.7%2.2%
1Yn/a-27.5%3.7%

Return vs Industry: Insufficient data to determine how 0R6Y performed against the UK Biotechs industry.

Return vs Market: Insufficient data to determine how 0R6Y performed against the UK Market.

Price Volatility

Is 0R6Y's price volatile compared to industry and market?
0R6Y volatility
0R6Y Average Weekly Movement7.1%
Biotechs Industry Average Movement7.9%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0R6Y's share price has been volatile over the past 3 months.

Volatility Over Time: 0R6Y's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2017n/aAlf Bjørsethhttps://www.thormedical.no

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. The company was founded in 2017 and is headquartered in Oslo, Norway.

Thor Medical ASA Fundamentals Summary

How do Thor Medical's earnings and revenue compare to its market cap?
0R6Y fundamental statistics
Market capkr240.55m
Earnings (TTM)-kr5.60m
Revenue (TTM)n/a

0.0x

P/S Ratio

-43.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0R6Y income statement (TTM)
Revenuekr0
Cost of Revenuekr0
Gross Profitkr0
Other Expenseskr5.60m
Earnings-kr5.60m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Aug 30, 2024

Earnings per share (EPS)-0.024
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did 0R6Y perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.